| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.05▲ | 1.05▲ | 1.06▲ | 1.22▼ | 1.22▼ |
| MA10 | 1.05▲ | 1.07▲ | 1.09▼ | 1.29▼ | 1.31▼ |
| MA20 | 1.06▲ | 1.12▼ | 1.19▼ | 1.34▼ | 1.67▼ |
| MA50 | 1.16▼ | 1.27▼ | 1.31▼ | 1.41▼ | 1.91▼ |
| MA100 | 1.26▼ | 1.31▼ | 1.35▼ | 1.86▼ | 1.94▼ |
| MA200 | 1.32▼ | 1.37▼ | 1.38▼ | 1.93▼ | 1.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.001▲ | -0.009▼ | -0.021▼ | -0.056▼ |
| RSI | 51.086▲ | 43.020▼ | 38.423▼ | 35.685▼ | 36.277▼ |
| STOCH | 57.500 | 35.296 | 35.481 | 29.278 | 29.809 |
| WILL %R | 0.000▲ | -37.500 | -56.522 | -81.367▼ | -89.631▼ |
| CCI | 79.717 | 13.995 | -44.135 | -179.269▼ | -148.614▼ |
|
Friday, March 13, 2026 01:02 AM
Just as important as the trial design is the formulation Entera plans to take into Phase 3 – the next-generation single-tablet version of EB613. Earlier clinical studies used a multi-tablet regimen, ...
|
|
Wednesday, March 11, 2026 11:45 AM
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), ...
|
|
Thursday, March 05, 2026 12:31 AM
Entera Bio is moving closer to what could become a major shift in the treatment of osteoporosis: the first oral anabolic therapy designed to rebuild bone. The biotechnology company announced yesterday ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/03/26 | 1.09 | 1.1757 | 0.9801 | 1.09 | 706,001 |
| 20/03/26 | 1.25 | 1.25 | 1.08 | 1.11 | 152,190 |
| 19/03/26 | 1.32 | 1.32 | 1.1201 | 1.19 | 287,996 |
| 18/03/26 | 1.385 | 1.43 | 1.30 | 1.34 | 101,253 |
| 17/03/26 | 1.35 | 1.48 | 1.3499 | 1.38 | 29,396 |
| 16/03/26 | 1.29 | 1.39 | 1.27 | 1.35 | 53,384 |
| 13/03/26 | 1.35 | 1.3685 | 1.26 | 1.27 | 51,356 |
| 12/03/26 | 1.35 | 1.4962 | 1.315 | 1.32 | 82,488 |
| 11/03/26 | 1.49 | 1.5699 | 1.32 | 1.39 | 227,135 |
| 10/03/26 | 1.37 | 1.50 | 1.35 | 1.49 | 101,292 |
|
|
||||
|
|
||||
|
|